Ramírez-Guerrero JA, Bueno-Albores S, Dávila-Quesada AE, Gutiérrez-Sougarret B, Piñón-Lozano R, Piñón-Holt D

Language: Spanish
References: 40
Page: 74-78
PDF size: 183.48 Kb.

ABSTRACT

We conducted a retrospective and prospective study to compare the effects of Dexmedetomidine (Dx) on the use of intravenous anesthetics, sedation level, hemodynamic changes, postoperative pain, nausea and vomiting. Methods: Seventy-eight ASA I-III patients scheduled for radiofrecuency ablations of saphenous vein with local anesthetics were included, 38 received Dx 1 µg/kg for 10 minutes. Maintenance was with midazolam, fentanyl and propofol for control of pain and level ≤ 2 sedation (OOA). Results: Demographic data were similar in both groups. The Dx group resulted in a significant reduction in use of midazolam and propofol, without changes in use of fentanyl. In 2007, 85% received propofol and in 2008 only 33% needed this. Dx resulted in a significant decrease in heart rate. Conclusions: Dx used during radiofrecuency ablations of saphenous veins reduced the use of midazolam and propofol, in some case propofol was not used. Hemodynamic changes were minimal.

REFERENCES

1. Roth SM. Endovenous radiofrequency ablation of superficial and perforator veins. Surg Clin N Am 2007;87:1267–1284.

2. Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, Schwam EM, Siegel JL. Validity and reliability of the Observer’s Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol 1990;10:244-51.

3. Kamibayashi T, Maze M. Clinical Uses of a2-Adrenergic Agonists. Anesthesiology 2000;93:1345–9.

4. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382–94.

5. Ramírez-Guerrero A, López-Velarde G. Usos de la clonidina en Anestesiología. Rev Mex Anest 1995;18:25-36.

6. Bellevile JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I: Sedation, ventilation and metabolic rate. Anesthesiology 1992;77:1125-1133.

7. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II: Hemodynamic changes. Anesthesiology 1992;77:1134-1142.

8. Bol CJ, Vogelaar JP, Tang JP, Mandema JW. Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat. J Pharmacol Exp Ther.

9. Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, Vedio A, Singer M, Feneck R, Treacher D, Willatts SM, Grounds RM. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999;54:1136-1142.

10. Peden CJ, Cloote AH, Stratford N, Prys-Roberts C. The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanyl. Anaesthesia 2001;56:408-13.

11. Forrest FC, Tooley MA, Saunders PR, Prys-Roberts C. Propofol infusion and the suppression of consciousness: the EEG and dose requirements. Br J Anaesth 1994;72:35-41.

12. Dutta S, Karol MD, Cohen T, Jones RM, Mant T. Effect of dexmedetomidine on propofol requirements in healthy subjects. J Pharm Sci 2001;90:172-181.

13. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000;90:699–705.

14. Angst MS, Ramaswamy B, Davies MF, Maze M. Comparative analgesic and mental effects of increasing plasma concentrations of dexmedetomidine and alfentanyl in humans. Anesthesiology 2004;101:744-752.

15. Idänpään-Heikkilä JJ, Kalso EA, Seppälä T. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli. J Pharmacol Exp Ther 1994;271:1306-13.

16. Eisenach JC, De Kock M, Klimscha W. Alpha(2)-adrenergic agonists for regional anesthesia: A clinical review of clonidine (1984–1995).Anesthesiology 1996;85:655–74.

17. Pensado A, Molins N, Alvarez J. Cardiovascular effects of a single dose of propofol in coronary patients with good ventricular function. Rev Esp Anestesiol Reanim 1994;41:147-51.

18. Robinson BJ, Ebert TJ, O’Brien TJ, Colinco MD, Muzi M. Mechanisms whereby propofol mediates peripheral vasolidation in humans: sympathoinhibition or direct vascular relaxation? Anesthesiology 1997;86:64-72.

19. Ebert TJ. Sympathetic and hemodynamic effects of moderate and deep sedation with propofol in humans. Anesthesiology 2005;103:20-24.

20. Wagner DS, Brummett CM. Dexmedetomidine: as safe as safe can be. Seminars in anesthesia, Perioperative Medicine and Pain 2006;25:77-83.

21. Ingersoll-Weng E, Manecke GR, Thistlethwaite PA. Dexmedetomidine and cardiac arrest. Anesthesiology 2004;100:738-739.

22. Berkenbosch JW, Tobias JD. Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med 2003;4:203–5.

23. Shahbaz R, Arain and Thomas J. Ebert: The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg 2002;95:461-466.

24. Jorden VS, Pousman RM, Sanford MM et al. Dexmedetomidine overdose in the perioperative setting. Ann Pharmacother 2004;38:803-807.

25. Taghinia AH, Shapiro FE, Slavin SA. Dexmedetomidine in aesthetic facial surgery: Improving anesthetic safety and efficacy. Plast Reconst Surg 2008;121: 269-276.

26. Greenhalgh DL, Kumar CM. Sedation during ophthalmic surgery. Eur J Anaesthesiol 2008;25:701-7.

27. Ayoglu H, Altunkaya H, Ozer Y, Yapakci O, Ozkocak I, Oz O, Alpay A, Ugurbas SH. Dexmedetomidine sedation during cataract surgery under regional anaesthesia. Br J Anaesth 2007;99:448.

28. Alhashemi JA. Dexmedetomidine vs midazolam for monitored anaesthesia care during cataract surgery. Br J Anaesth 2006;96:722-6.

29. Ogawa S, Seino H, Ito H, Yamazaki S, Ganzberg S, Kawaai H. Intravenous sedation with low-dose dexmedetomidine: its potential for use in dentistry. Anesth Prog 2008Fall;55:82-8.

30. Cheung CW, Ying CL, Chiu WK, Wong GT, Ng KF, Irwin MG. A comparison of dexmedetomidine and midazolam for sedation in third molar surgery. Anaesthesia 2007;62:1132-8.

31. Jense RJ, Souter K, Davies J, Romig C, Panneerselvam A, Maronian N. Dexmedetomidine sedation for laryngeal framework surgery. Ann Otol Rhinol Laryngol 2008;117:659-64.

32. Ohata H, Tanemura E, Dohi S. Use of high-dose dexmedetomidine infusion for anesthesia and sedation in a patient for microlaryngeal surgery maintained with spontaneous breathing. Masui 2008;57:428-32.

33. Pambianco DJ. Future directions in endoscopic sedation. Gastrointest Endosc Clin N Am 2008;18:789-99.

34. Rozet I. Anesthesia for functional neurosurgery: the role of dexmedetomidine. Curr Opin Anaesthesiol 2008;21:537-43.

35. Frost EA, Booij LH. Anesthesia in the patient for awake craniotomy. Curr Opin Anaesthesiol 2007;20:331-5.

36. Souter MJ, Rozet I, Ojemann JG, Souter KJ, Holmes MD, Lee L, Lam AM. Dexmedetomidine sedation during awake craniotomy for seizure resection: effects on electrocorticography. J Neurosurg Anesthesiol 2007;19:38-44.

37. Everett LL, van Rooyen IF, Warner MH, Shurtleff HA, Saneto RP, Ojemann JG, Everett LL, van Rooyen IF, Warner MH, Shurtleff HA, Saneto RP, Ojemann JG. Use of dexmedetomidine in awake craniotomy in adolescents: report of two cases. Paediatr Anaesth 2006;16:338-42.

38. Mason KP, Zgleszewski SE, Prescilla R, Fontaine PJ, Zurakowski D. Hemodynamic effects of dexmedetomidine sedation for CT imaging studies. Paediatr Anaesth 2008;18:393-402.

39. Mason KP, Zurakowski D, Zgleszewski SE, Robson CD, Carrier M, Hickey PR, Dinardo JA. High dose dexmedetomidine as the sole sedative for pediatric MRI. High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth 2008;18:403-11.

40. Mason KP, Zgleszewski SE, Dearden JL, Dumont RS, Pirich MA, Stark CD, D’Angelo P, Macpherson S, Fontaine PJ, Connor L, Zurakowski D. Dexmedetomidine for pediatric sedation for computed tomography imaging studies. Anesth Analg 2006;103:57-62.